| Abstrakt: |
For the months of September and October 2022, APBN looks at toxins from the natural world and consider its benefits to humanity despite the negative connotation. First up, we have a contribution from Vanessa Lunardi on snake venoms in venom therapy. Then Tara Ng dives into plant secondary metabolites, its properties, and potential applications. While not wholly related to venom therapy, Chang Wei and Dr Mohd Redzwan Sabran from the University of Putra Malaysia, discuss a family of fungal toxins called aflatoxins, its toxic effects, and how probiotics might have aflatoxin-reducing properties. Other highlights in this issue include a column by Dr Chen Min Wei, Consultant Surgeon from the National Neuroscience Institute, and Samuel Choo, Co-Founder and Head of Product at Kyalio, on how immersive virtual reality is bridging the gap between studying and performing surgery, and an interview with Andreas Joergensen, Managing Director of the SEA Cluster at Organon, on women's healthcare and reproductive health awareness in Asia. [ABSTRACT FROM AUTHOR] |
